A groundbreaking CRISPR-based tool has been developed to analyze cancer cells directly from patients, revealing critical genetic drivers of acute myeloid leukemia (AML). This innovative approach...
Recent research has revealed that cancer cells possess a backup metabolic pathway that enables them to continue constructing DNA, even when their primary method is hindered....
